Costs of breast cancer care in Mexico

Analysis of two insurance coverage scenarios

María Cecilia González-Robledo, Rebeca Wong, Héctor Arreola Ornelas, Felicia Marie Knaul

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Breast cancer (BC) is a major cause of disease and death worldwide. In addition to its contribution to mortality and disability, it is a major economic burden both public and private. Objective: To estimate the average direct medical cost/year of care for the diagnosis and treatment of BC in two coverage scenarios in Mexico: What is 'ideal' based on service usage patterns according to international guidelines and what is 'current' using the service usage patterns of suppliers in Mexico. Material and Methods: The pattern and intensity of use of procedures for the care of BC in the Mexican Social Security Institute (IMSS) for 2009 were identified and prices were associated using the guidelines from the System of Social Protection in Health (SPSS) and the IMSS for the current scenario and the ideal scenario, international patterns (Breast Health Global Initiative BHGI after its acronym in English) were used and prices were associated from the SPSS guidelines. Results: The annual average direct medical cost per patient in the 'current' scenario was 8557 US$, while the cost in the 'ideal' scenario was 4554 US$. There are differences in costs between 'what we do' and 'what should be done', due to differences in the implementation of the interventions for the treatment of the different stages of the disease. A proportional increase in the average cost was also identified as the diagnosis stage advanced (from I to III). Conclusions: Given that in Mexico there is universal insurance coverage for the treatment of BC, it is necessary to use economic resources more efficiently. It is necessary to continue to examine this topic in more depth and the next step will be to assess the effectiveness of both scenarios in order to provide enough evidence for the decision-making process.

Original languageEnglish (US)
Article number587
Journalecancermedicalscience
Volume9
DOIs
StatePublished - Oct 28 2015

Fingerprint

Insurance Coverage
Mexico
Breast Neoplasms
Costs and Cost Analysis
Social Security
Guidelines
Economics
Universal Coverage
Public Policy
Health Care Costs
Cause of Death
Decision Making
Breast
Therapeutics
Mortality
Health

Keywords

  • Breast neoplasms
  • Direct service costs
  • Health financing
  • Mexico

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Costs of breast cancer care in Mexico : Analysis of two insurance coverage scenarios. / González-Robledo, María Cecilia; Wong, Rebeca; Ornelas, Héctor Arreola; Knaul, Felicia Marie.

In: ecancermedicalscience, Vol. 9, 587, 28.10.2015.

Research output: Contribution to journalArticle

González-Robledo, María Cecilia ; Wong, Rebeca ; Ornelas, Héctor Arreola ; Knaul, Felicia Marie. / Costs of breast cancer care in Mexico : Analysis of two insurance coverage scenarios. In: ecancermedicalscience. 2015 ; Vol. 9.
@article{d05e89268d314031996f01211a1b9ec5,
title = "Costs of breast cancer care in Mexico: Analysis of two insurance coverage scenarios",
abstract = "Background: Breast cancer (BC) is a major cause of disease and death worldwide. In addition to its contribution to mortality and disability, it is a major economic burden both public and private. Objective: To estimate the average direct medical cost/year of care for the diagnosis and treatment of BC in two coverage scenarios in Mexico: What is 'ideal' based on service usage patterns according to international guidelines and what is 'current' using the service usage patterns of suppliers in Mexico. Material and Methods: The pattern and intensity of use of procedures for the care of BC in the Mexican Social Security Institute (IMSS) for 2009 were identified and prices were associated using the guidelines from the System of Social Protection in Health (SPSS) and the IMSS for the current scenario and the ideal scenario, international patterns (Breast Health Global Initiative BHGI after its acronym in English) were used and prices were associated from the SPSS guidelines. Results: The annual average direct medical cost per patient in the 'current' scenario was 8557 US$, while the cost in the 'ideal' scenario was 4554 US$. There are differences in costs between 'what we do' and 'what should be done', due to differences in the implementation of the interventions for the treatment of the different stages of the disease. A proportional increase in the average cost was also identified as the diagnosis stage advanced (from I to III). Conclusions: Given that in Mexico there is universal insurance coverage for the treatment of BC, it is necessary to use economic resources more efficiently. It is necessary to continue to examine this topic in more depth and the next step will be to assess the effectiveness of both scenarios in order to provide enough evidence for the decision-making process.",
keywords = "Breast neoplasms, Direct service costs, Health financing, Mexico",
author = "Gonz{\'a}lez-Robledo, {Mar{\'i}a Cecilia} and Rebeca Wong and Ornelas, {H{\'e}ctor Arreola} and Knaul, {Felicia Marie}",
year = "2015",
month = "10",
day = "28",
doi = "10.3332/ecancer.2015.587",
language = "English (US)",
volume = "9",
journal = "ecancermedicalscience",
issn = "1754-6605",
publisher = "Cancer Intellilgence",

}

TY - JOUR

T1 - Costs of breast cancer care in Mexico

T2 - Analysis of two insurance coverage scenarios

AU - González-Robledo, María Cecilia

AU - Wong, Rebeca

AU - Ornelas, Héctor Arreola

AU - Knaul, Felicia Marie

PY - 2015/10/28

Y1 - 2015/10/28

N2 - Background: Breast cancer (BC) is a major cause of disease and death worldwide. In addition to its contribution to mortality and disability, it is a major economic burden both public and private. Objective: To estimate the average direct medical cost/year of care for the diagnosis and treatment of BC in two coverage scenarios in Mexico: What is 'ideal' based on service usage patterns according to international guidelines and what is 'current' using the service usage patterns of suppliers in Mexico. Material and Methods: The pattern and intensity of use of procedures for the care of BC in the Mexican Social Security Institute (IMSS) for 2009 were identified and prices were associated using the guidelines from the System of Social Protection in Health (SPSS) and the IMSS for the current scenario and the ideal scenario, international patterns (Breast Health Global Initiative BHGI after its acronym in English) were used and prices were associated from the SPSS guidelines. Results: The annual average direct medical cost per patient in the 'current' scenario was 8557 US$, while the cost in the 'ideal' scenario was 4554 US$. There are differences in costs between 'what we do' and 'what should be done', due to differences in the implementation of the interventions for the treatment of the different stages of the disease. A proportional increase in the average cost was also identified as the diagnosis stage advanced (from I to III). Conclusions: Given that in Mexico there is universal insurance coverage for the treatment of BC, it is necessary to use economic resources more efficiently. It is necessary to continue to examine this topic in more depth and the next step will be to assess the effectiveness of both scenarios in order to provide enough evidence for the decision-making process.

AB - Background: Breast cancer (BC) is a major cause of disease and death worldwide. In addition to its contribution to mortality and disability, it is a major economic burden both public and private. Objective: To estimate the average direct medical cost/year of care for the diagnosis and treatment of BC in two coverage scenarios in Mexico: What is 'ideal' based on service usage patterns according to international guidelines and what is 'current' using the service usage patterns of suppliers in Mexico. Material and Methods: The pattern and intensity of use of procedures for the care of BC in the Mexican Social Security Institute (IMSS) for 2009 were identified and prices were associated using the guidelines from the System of Social Protection in Health (SPSS) and the IMSS for the current scenario and the ideal scenario, international patterns (Breast Health Global Initiative BHGI after its acronym in English) were used and prices were associated from the SPSS guidelines. Results: The annual average direct medical cost per patient in the 'current' scenario was 8557 US$, while the cost in the 'ideal' scenario was 4554 US$. There are differences in costs between 'what we do' and 'what should be done', due to differences in the implementation of the interventions for the treatment of the different stages of the disease. A proportional increase in the average cost was also identified as the diagnosis stage advanced (from I to III). Conclusions: Given that in Mexico there is universal insurance coverage for the treatment of BC, it is necessary to use economic resources more efficiently. It is necessary to continue to examine this topic in more depth and the next step will be to assess the effectiveness of both scenarios in order to provide enough evidence for the decision-making process.

KW - Breast neoplasms

KW - Direct service costs

KW - Health financing

KW - Mexico

UR - http://www.scopus.com/inward/record.url?scp=84960464939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960464939&partnerID=8YFLogxK

U2 - 10.3332/ecancer.2015.587

DO - 10.3332/ecancer.2015.587

M3 - Article

VL - 9

JO - ecancermedicalscience

JF - ecancermedicalscience

SN - 1754-6605

M1 - 587

ER -